The company, which is developing cancer treatments, plans to trade on the Nasdaq Global Market.
{iframe}https://www.bizjournals.com/washington/news/2021/01/20/gaithersburg-biotech-neximmune-files-for-ipo.amp.html{/iframe}
Gaithersburg biotech NexImmune files for IPO – Washington Business Journal